Immunotherapy gets ‘meaningful’ win for survival in operable stomach cancer

(MedPage Today) – Berlin – In a global phase III trial, adding durvalumab (Imfinzi) to standard chemotherapy before and after surgery resulted in a statistically significant and “clinically meaningful” improvement in survival in patients…